We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CytoGenix Announces Completion of synDNA™ Production Module Prototype
News

CytoGenix Announces Completion of synDNA™ Production Module Prototype

CytoGenix Announces Completion of synDNA™ Production Module Prototype
News

CytoGenix Announces Completion of synDNA™ Production Module Prototype

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CytoGenix Announces Completion of synDNA™ Production Module Prototype "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CytoGenix, Inc. has announced that the prototype version of the synDNA™ production module was completed on schedule.

The device was designed for the commercial production of cell-free DNA by the leading international biopharmaceutical plant design, engineering and construction firm of Alfa Laval Biokinetics, Philadelphia, Pennsylvania.

It was tested by Alfa Laval engineers and CytoGenix senior scientists. The final version will be mounted on a stainless steel cart and have the capacity to produce up to 10 grams of high-purity DNA in 24 hours.

Kurt Berens, CytoGenix, Inc. Vice President of Product Development, commented, "This is an important step in our overall plan to construct a cGMP manufacturing facility."

"We plan to install several synDNA™ production modules to meet the growing demand for clinical-grade DNA internally and from customers."

Advertisement